Protagonist Therapeutics Inc. (PTGX) Stock Skyrockets Following Removal of Clinical Hold on Rusfertide Trials
Protagonist Therapeutics Inc. (PTGX) stock prices were up by 94.90% just before market trading commenced on October 11th, 2021. This brought the price per share